Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

The document is a detailed medical reference on skin and genetic disorders.

The document explains various skin conditions and their treatments.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.